TREACE MEDICAL CONCEPTS INC (TMCI)

US89455T1097 - Common Stock

7.79  -0.11 (-1.39%)

After market: 7.79 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
94.4M
64.46%
141.8M
50.21%
187.118M
31.96%
211.72M
13.15%
229.43M
8.36%
251.29M
9.53%
264.59M
5.29%
364.85M
37.89%
EBITDA
YoY % growth
-15.81M
-849.29%
-32.67M
-106.64%
-46.076M
-41.03%
-13.197M
71.36%
-254.827K
98.07%
4.503M
1,867.08%
4.794M
6.46%
34.374M
617.02%
EBIT
YoY % growth
-16.5M
-1,933.33%
-34.8M
-110.91%
-51.428M
-47.78%
-59.065M
-14.85%
-46.188M
21.80%
-41.833M
9.43%
-44.37M
-6.06%
-21.726M
51.03%
Operating Margin
-17.48%-24.54%-27.48%-27.90%-20.13%-16.65%-16.77%-5.95%
EPS
YoY % growth
-0.41-0.77
-87.80%
-0.81
-5.19%
-0.94
-16.48%
-0.77
18.74%
-0.69
9.53%
-0.48
30.88%
-0.26
46.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.04
62.60%
-0.26
13.64%
-0.25
14.88%
-0.23
9.42%
-0.04
-3.63%
-0.32
-22.05%
-0.28
-11.57%
-0.18
18.92%
0.05
231.58%
Revenue
Q2Q % growth
68.246M
9.70%
53.973M
5.61%
50.712M
14.07%
49.96M
10.81%
76.355M
11.88%
55.621M
3.05%
53.458M
5.41%
53.244M
6.57%
82.049M
7.46%
EBITDA
Q2Q % growth
9.306M
750.77%
-6.138M
64.02%
-5.09M
70.68%
-3.111M
65.25%
14.525M
56.08%
-8.191M
-33.44%
-5.732M
-12.63%
275.4K
108.85%
19.931M
37.22%
EBIT
Q2Q % growth
-2.26M
66.67%
-16.861M
11.11%
-15.634M
26.88%
-13.739M
9.22%
1.811M
180.12%
-18.901M
-12.10%
-16.585M
-6.08%
-10.792M
21.46%
4.437M
145.00%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.25
10.71%
-0.280.039.78%
Q2 2024
Q2Q % growth
-0.29
-45.00%
-0.300.011.96%
Q1 2024
Q2Q % growth
-0.30
-30.43%
-0.310.012.89%
Q4 2023
Q2Q % growth
-0.10
-25.00%
-0.09-0.01-10.69%
Q3 2023
Q2Q % growth
-0.28
-27.27%
-0.27-0.01-5.00%
Q2 2023
Q2Q % growth
-0.20
35.48%
-0.240.0417.73%
Q1 2023
Q2Q % growth
-0.23
-43.75%
-0.230.001.24%
Q4 2022
Q2Q % growth
-0.08
33.33%
-0.140.0643.98%
Q3 2022
Q2Q % growth
-0.22
-83.33%
-0.290.0724.98%
Q2 2022
Q2Q % growth
-0.31
-210.00%
-0.21-0.10-48.25%
Q1 2022
Q2Q % growth
-0.16
-128.57%
-0.210.0522.54%
Q4 2021
Q2Q % growth
-0.12 -0.01-0.11-2,252.94%
Q3 2021
Q2Q % growth
-0.12 -0.120.001.96%
Q2 2021
Q2Q % growth
-0.10 -0.120.0218.30%
Q1 2021
Q2Q % growth
-0.07 -0.06-0.01-14.38%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
45.086M
10.62%
44.354M732K1.65%
Q2 2024
Q2Q % growth
44.455M
5.96%
43.86M595K1.36%
Q1 2024
Q2Q % growth
51.108M
21.12%
50.046M1.062M2.12%
Q4 2023
Q2Q % growth
62.212M
25.00%
61.761M451K0.73%
Q3 2023
Q2Q % growth
40.758M
23.28%
42.896M-2.138M-4.98%
Q2 2023
Q2Q % growth
41.953M
39.98%
41.665M288K0.69%
Q1 2023
Q2Q % growth
42.195M
45.25%
40.03M2.165M5.41%
Q4 2022
Q2Q % growth
49.77M
48.83%
45.645M4.125M9.04%
Q3 2022
Q2Q % growth
33.06M
52.91%
30.668M2.392M7.80%
Q2 2022
Q2Q % growth
29.97M
45.13%
29.206M764K2.62%
Q1 2022
Q2Q % growth
29.05M
55.26%
26.554M2.496M9.40%
Q4 2021
Q2Q % growth
33.44M
38.76%
32.912M528K1.60%
Q3 2021
Q2Q % growth
21.62M
51.51%
21.42M200K0.93%
Q2 2021
Q2Q % growth
20.65M
166.80%
19.312M1.338M6.93%
Q1 2021
Q2Q % growth
18.71M
66.16%
19.142M-432K-2.26%
Q4 2020
Q2Q % growth
24.1M
43.97%
%
Q3 2020
Q2Q % growth
14.27M
60.52%
%
Q2 2020
Q2Q % growth
7.74M
-1.90%
%
Q1 2020
Q2Q % growth
11.26M
90.85%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 30.63% 0% 1.6%
Revenue0% -0.99% 0% 0.78%